Skip Navigation

Cardiovascular Research 2002 53(4):1010-1018; doi:10.1016/S0008-6363(01)00535-1
© 2002 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rodriguez-Porcel, M.
Right arrow Articles by Lerman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez-Porcel, M.
Right arrow Articles by Lerman, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2002, European Society of Cardiology

Chronic antioxidant supplementation attenuates nuclear factor-{kappa}B activation and preserves endothelial function in hypercholesterolemic pigs

Martin Rodriguez-Porcela, Lilach O Lermanb, David R Holmes, Jr.a, Darcy Richardsona, Claudio Napolic,d and Amir Lermana,*

aDepartment of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
bDepartment of Internal Medicine, Division of Hypertension, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
cDepartment of Medicine, University of Naples, Naples, Italy
dDepartment of Medicine—0682, University of California, San Diego, CA, USA

* Corresponding author. Tel.: +1-507-255-4152; fax: +1-507-255-2550 lerman.amir{at}mayo.edu

Objective: Hypercholesterolemia (HC), a pro-oxidant condition, activates nuclear factor-kappa beta (NF-{kappa}B) and is associated with coronary endothelial dysfunction. The physiological significance of in vivo chronic antioxidant intervention on HC-induced NF-{kappa}B activation and coronary endothelial function remains unclear. Methods: Four groups of pigs were studied after 12 weeks of normal diet, normal diet with concomitant antioxidant intervention (100 IU/kg of vitamin E and 1 g of vitamin C daily), 2% HC diet, or HC diet+antioxidant supplementation. NF-{kappa}B activation and the nitric oxide (NO) pathway were investigated by Western blotting and immunohistochemistry, while oxidative stress was evaluated by coronary artery tissue radical scavenger activity and levels of vitamin E and C. Endothelial function was studied in vitro by coronary vasoreactivity to bradykinin and substance P. Results: HC animals had increased activation of NF-{kappa}B, decreased endothelial NO synthase expression, and decreased radical scavenger system activity, associated with impaired coronary endothelial function. Antioxidant supplementation in HC normalized NF-{kappa}B activation and NO bioactivity, and preserves coronary endothelial function. Conclusions: This study demonstrates for the first time that in vivo chronic interruption of the endogenous oxidative stress cascade reduces HC-induced NF-{kappa}B activation and normalizes NO bioactivity in association with preservation of coronary endothelial function. This study suggests a role for increased oxidative stress and NF{kappa}B activation in early atherosclerosis.

KEYWORDS Atherosclerosis; Coronary circulation; Endothelial function; Free radicals


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
Y. Takami, H. Nakagami, R. Morishita, T. Katsuya, H. Hayashi, M. Mori, H. Koriyama, Y. Baba, O. Yasuda, H. Rakugi, et al.
Potential Role of CYLD (Cylindromatosis) as a Deubiquitinating Enzyme in Vascular Cells
Am. J. Pathol., March 1, 2008; 172(3): 818 - 829.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Lavi, E. H. Yang, A. Prasad, V. Mathew, G. W. Barsness, C. S. Rihal, L. O. Lerman, and A. Lerman
The Interaction Between Coronary Endothelial Dysfunction, Local Oxidative Stress, and Endogenous Nitric Oxide in Humans
Hypertension, January 1, 2008; 51(1): 127 - 133.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Herrmann, A. M. Saguner, D. Versari, T. E. Peterson, A. Chade, M. Olson, L. O. Lerman, and A. Lerman
Chronic Proteasome Inhibition Contributes to Coronary Atherosclerosis
Circ. Res., October 26, 2007; 101(9): 865 - 874.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Mannheim, D. Versari, E. Daghini, M. Gossl, O. Galili, A. Chade, V. S. Rajkumar, E. L. Ritman, L. O. Lerman, and A. Lerman
Impaired myocardial perfusion reserve in experimental hypercholesterolemia is independent of myocardial neovascularization
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2449 - H2458.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. Daghini, A. R. Chade, J. D. Krier, D. Versari, A. Lerman, and L. O. Lerman
Acute inhibition of the endogenous xanthine oxidase improves renal hemodynamics in hypercholesterolemic pigs
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R609 - R615.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. Versari, E. Daghini, M. Rodriguez-Porcel, K. Sattler, O. Galili, K. Pilarczyk, C. Napoli, L. O. Lerman, and A. Lerman
Chronic Antioxidant Supplementation Impairs Coronary Endothelial Function and Myocardial Perfusion in Normal Pigs
Hypertension, March 1, 2006; 47(3): 475 - 481.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
O. Galili, K. J. Sattler, J. Herrmann, J. Woodrum, M. Olson, L. O. Lerman, and A. Lerman
Experimental hypercholesterolemia differentially affects adventitial vasa vasorum and vessel structure of the left internal thoracic and coronary arteries
J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 767 - 772.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Herrmann, S. Samee, A. Chade, M. R. Porcel, L. O. Lerman, and A. Lerman
Differential Effect of Experimental Hypertension and Hypercholesterolemia on Adventitial Remodeling
Arterioscler Thromb Vasc Biol, February 1, 2005; 25(2): 447 - 453.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. J.E. Sattler, J. E. Woodrum, O. Galili, M. Olson, S. Samee, F. B. Meyer, X.-Y. Zhu, L. O. Lerman, and A. Lerman
Concurrent Treatment With Renin-Angiotensin System Blockers and Acetylsalicylic Acid Reduces Nuclear Factor {kappa}B Activation and C-Reactive Protein Expression in Human Carotid Artery Plaques
Stroke, January 1, 2005; 36(1): 14 - 20.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Gossl, P. E. Beighley, N. M. Malyar, and E. L. Ritman
Role of vasa vasorum in transendothelial solute transport in the coronary vessel wall: a study with cryostatic micro-CT
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2346 - H2351.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X.-Y. Zhu, A. R. Chade, M. Rodriguez-Porcel, M. D. Bentley, E. L. Ritman, A. Lerman, and L. O. Lerman
Cortical Microvascular Remodeling in the Stenotic Kidney: Role of Increased Oxidative Stress
Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1854 - 1859.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. R. Chade, J. D. Krier, M. Rodriguez-Porcel, J. F. Breen, M. A. McKusick, A. Lerman, and L. O. Lerman
Comparison of acute and chronic antioxidant interventions in experimental renovascular disease
Am J Physiol Renal Physiol, June 1, 2004; 286(6): F1079 - F1086.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
X.-Y. Zhu, M. Rodriguez-Porcel, M. D. Bentley, A. R. Chade, V. Sica, C. Napoli, N. Caplice, E. L. Ritman, A. Lerman, and L. O. Lerman
Antioxidant Intervention Attenuates Myocardial Neovascularization in Hypercholesterolemia
Circulation, May 4, 2004; 109(17): 2109 - 2115.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. R. Chade, M. Rodriguez-Porcel, J. Herrmann, X. Zhu, J. P. Grande, C. Napoli, A. Lerman, and L. O. Lerman
Antioxidant Intervention Blunts Renal Injury in Experimental Renovascular Disease
J. Am. Soc. Nephrol., April 1, 2004; 15(4): 958 - 966.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Rodriguez-Porcel, J. Herrman, A. R. Chade, J. D. Krier, J. F. Breen, A. Lerman, and L. O. Lerman
Long-Term Antioxidant Intervention Improves Myocardial Microvascular Function in Experimental Hypertension
Hypertension, February 1, 2004; 43(2): 493 - 498.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Herrmann, A. Ciechanover, L. O Lerman, and A. Lerman
The ubiquitin-proteasome system in cardiovascular diseases--a hypothesis extended
Cardiovasc Res, January 1, 2004; 61(1): 11 - 21.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Rodriguez-Porcel, L. O. Lerman, J. Herrmann, T. Sawamura, C. Napoli, and A. Lerman
Hypercholesterolemia and Hypertension Have Synergistic Deleterious Effects on Coronary Endothelial Function
Arterioscler Thromb Vasc Biol, May 1, 2003; 23(5): 885 - 891.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.